Dr. Harish Muniswamy, MD

Dr. Muniswamy practices at Texas Health Arlington Memorial Hospital in Arlington, Texas, part of Texas Health Resources.

Dr. Muniswamy's NPI, 1205939337, was assigned on September 6, 2006. Dr. Muniswamy holds Texas license N0300.

Dr. Muniswamy's primary practice is Texas Health Arlington Memorial Hospital, at 800 W Randol Mill Rd, Arlington, TX 76012 in Tarrant County. The practice phone is (817) 548-6200.

Dr. Muniswamy's primary practice is Texas Health Arlington Memorial Hospital in Arlington, Texas, part of Texas Health Resources. Dr. Muniswamy is also affiliated with Medical City Arlington Hospital. The medical group on file is Sound Physicians. Dmand AI also links Dr. Muniswamy to 4 more hospitals, 2 medical groups, 1 physician office and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Muniswamy practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Muniswamy's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Muniswamy's licenses on file in 3 states: Texas, New York and Tennessee.

CMS data shows 7,271 Medicare services from Dr. Muniswamy across 8 procedure codes in 2024, for 826 Medicare patients. Medicare paid $473,158 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 826 Medicare patients who saw Dr. Muniswamy in 2024. The largest group is 75 to 84, with 319 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Muniswamy's median patient age at 71, with 56% women.

In 2024, Dr. Muniswamy wrote 1,502 Medicare Part D claims for 334 patients. 82% of them were for generic drugs. CMS names the drug for 961 of them, across 33 drugs with 11 or more claims each, at $47,292 in total drug cost. In 2023, CMS named 624 claims across 25 drugs.

Dr. Muniswamy accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 84 general payments to Dr. Muniswamy from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $292.